On November 6, 2025, Shanghai, China, CorrectSequence Therapeutics Co., Ltd. (Correctseq), a clinical-stage biotechnology ...

Aziz Ansari, an award-winning actor, director, writer and comedian, brings his “Hypothetical Tour” to the Gallo Center. He co ...

Cas9 gene editing and artificial intelligence to create compact tomato plants optimized for vertical farming in ...

VRTX's new drugs deliver a mixed Q3 performance. Alyftrek sales surge. Journavx and Casgevy lag expectations but show promise.

Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of ...

Intellia Therapeutics finds itself navigating a significant crisis as regulatory developments overshadowed the release of its ...

Cathie Wood’s Ark Invest has made a series of portfolio adjustments. The firm trimmed exposure to several biotech companies ...

Emerging biotechnologies, strategic collaborations, and growing focus on personalized and regenerative medicine are accelerating the next wave of gene therapy innovation.Austin, Nov. 05, 2025 (GLOBE ...

Cathie Wood's ARK Invest bought $17M in CRISPR and Beam gene-editing stocks while selling Teradyne, Roku, and SoFi shares on ...

Genetically modified organisms, also known as GMOs, have been a hot topic of conversation among researchers, producers, ...

Cathie Wood's Ark Invest sold shares of five biotech and healthcare companies in recent trades. She also offloaded over 1.1 ...

Our new but simple method is far more effective and can now be applied to a much wider range of plant species than our ...